Gedeon Richter Pharma GmbH

What Gedeon Richter Pharma GmbH does

Gedeon Richter Pharma GmbH is the German commercial subsidiary of the Hungary-headquartered Gedeon Richter pharmaceutical Group, operating in Germany since 2011. The entity distributes the Group's pharmaceutical products in the German market across two therapeutic pillars: women's health, covering contraception, endometriosis, fertility, menopause, and uterine fibroids; and biosimilars, focused on rheumatology/osteoporosis and immunology. Customer-facing activity is directed at healthcare professionals, with a dedicated HCP engagement asset in Campus Frauengesundheit, an information, service, and continuing education portal for gynecologists.

The German subsidiary sits on top of a Group-level R&D and manufacturing platform anchored by a Budapest research center described as the most important pharmaceutical research center in Central-Eastern Europe, staffed by over 1,200 R&D personnel. The Group produces more than 2,800 products internationally and operates its own proprietary sales and distribution network spanning five continents, serving patients in over 100 countries. Women's health and biosimilars/biotechnology are supplemented by ongoing basic research into new chemical entities, with biotechnology formally adopted as a strategic area in 2006.

The business model is direct pharmaceutical sales through prescription and institutional channels, with regulated pricing rather than disclosed list pricing. Products reach end prescribers through the Group's own international sales network rather than via third-party distributors. The Group has stated an explicit strategic objective of becoming a significant player in the league of European-headquartered mid-sized pharmaceutical companies, leveraging its three specialty areas of basic research, women's health, and biotechnology/biosimilars.

Name

Gedeon Richter Pharma GmbH

Legal name

Gedeon Richter Pharma GmbH

Website

https://gedeonrichter.de

Company type

Private

Operating status

Operating

Headcount range

251–500 employees

Short description

Gedeon Richter Pharma GmbH is the German commercial subsidiary of the Hungary-based Gedeon Richter pharmaceutical Group, distributing women's health products (contraception, endometriosis, fertility, menopause, uterine fibroids) and biosimilars (osteoporosis, rheumatology, immunology) to German healthcare professionals since 2011.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN)

akta.pro secondary industry

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)

Keywords

• Pharmaceutical products
• Women's health medications
• Biosimilar drugs
• Osteoporosis treatments
• Contraceptive medications

Headquarters

HQ city

Budapest

HQ country

Hungary

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain

Revenue model

1. Pharmaceutical Product Sales: Sale of proprietary and generic pharmaceutical products including women's health medications, biosimilars, and other therapeutic solutions through international distribution network

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Gedeon Richter Pharma GmbH is the German subsidiary of the Hungarian pharmaceutical company Gedeon Richter. It develops, manufactures, and distributes pharmaceutical products primarily focused on women's health (covering contraception, endometriosis, fertility, menopause, and uterine fibroids) and biosimilars (rheumatology/osteoporosis and immunology). The German subsidiary has been serving women across all life phases since 2011, operating within a group that produces over 2,800 products internationally and serves patients in over 100 countries.

Product overview

Gedeon Richter is a pharmaceutical company with headquarters in Hungary, representing itself through a distribution network on five continents. The company produces over 2,800 products internationally and supplies patients in over 100 countries with therapeutic solutions. In Germany, the company focuses on women's health and osteoporosis. The product portfolio consists of two core areas: (1) Women's Health covering contraception, endometriosis, fertility, menopause, and uterine fibroids; and (2) Biosimilars focusing on rheumatology/osteoporosis and immunology. Additionally, the company operates Campus Frauengesundheit, an information and continuing education portal for gynecologists.

Differentiator

Problem solved

Functional benefit

Brands

• Campus Frauengesundheit: An information, service and training portal for gynecologists, providing comprehensive platform for women's health professionals.

Products and services

• Women's Health Pharmaceuticals Comprehensive pharmaceutical product portfolio for women's health covering contraception, endometriosis, fertility, menopause, and uterine fibroids. Targeted at gynecologists and women's healthcare providers across Germany and international markets.
• Biosimilar Pharmaceuticals Biosimilar pharmaceutical products focusing on rheumatology/osteoporosis and immunology. Targeted at rheumatologists, immunologists, and other specialists treating osteoporosis and autoimmune conditions, offering affordable biologic treatment alternatives.

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered minor.

• ALLWINminorOthersSubsidiary/organization affiliated with Gedeon Richter Group, logo displayed in footer. Nature of relationship not explicitly detailed in available content.
• BigFishminorOthersHungarian digital/technology company affiliated with Richter Group, logo displayed in footer. Nature of collaboration not explicitly detailed in available content.

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Theramex: Global specialty pharmaceutical company focused exclusively on women's health (contraception, menopause, fertility), competing head-to-head with Gedeon Richter's core women's health franchise in Europe.
• Organon & Co. US-listed women's health spinoff from Merck that operates a dedicated women's health portfolio (contraception, fertility, menopause) plus biosimilars — the closest direct comparable in product mix and target prescriber.
• Ferring Pharmaceuticals: Swiss-headquartered specialty pharma with deep reproductive health, fertility, and women's health franchises, competing in the same gynecologist channel across Germany and broader Europe.
• Exeltis: Specialty pharma division focused on women's health and reproductive medicine globally, with a comparable product mix in contraception, menopause, and fertility treatments.

Broad incumbents

• Viatris: Global generics and branded specialty pharma with established women's health and biosimilar franchises; competes with Gedeon Richter in similar therapeutic areas across European markets.
• Sandoz Group: Global biosimilars and generics leader; directly comparable on Gedeon Richter's biosimilar franchise in rheumatology, osteoporosis, and immunology.
• Bayer AG (Pharmaceuticals): German pharmaceutical incumbent whose portfolio includes major women's health and contraception assets and operates the same domestic market with substantially larger scale and marketing budget.
• Teva Pharmaceutical Industries: Global generics and specialty pharma with women's health, biosimilars, and CNS exposure; comparable on biosimilar strategy and on the regulatory-driven generics economics in Germany.

Regional players

• STADA Arzneimittel: German-headquartered generics and specialty pharma with strong distribution and presence in the German market; comparable as a domestic European player competing in similar reimbursement dynamics.
• Zentiva: European generics manufacturer with significant Central and Eastern European operations, directly comparable on CEE-based low-cost pharma manufacturing and broad European generics distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/gedeon-richter-pharma-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gedeon Richter Pharma GmbH